These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33280624)

  • 21. Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.
    Alzouby S; Baig K; Alrabiah F; Shibl A; Al-Nakhli D; Senok AC
    J Infect Public Health; 2020 Jul; 13(7):1012-1017. PubMed ID: 31831398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of Clostridioides difficile Infection in Portugal: A Retrospective, Observational Study of Hospitalized Patients.
    Nazareth C; Leitão I; Reis E; Inácio H; Martins F; Ramalheira E; Cunha F; Santos C; Lino S; Moreira H; Kruptsala N; Santos A; Paixão L; Pássaro L; Oleastro M
    Acta Med Port; 2022 Apr; 35(4):270-278. PubMed ID: 35380943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital-acquired Clostridioides difficile infections in Alberta: The validity of laboratory-identified event surveillance versus clinical infection surveillance.
    Almond J; Leal J; Bush K; Rogers E; Henderson EA; Ellison J
    Am J Infect Control; 2020 Jun; 48(6):633-637. PubMed ID: 31733811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland.
    Robertson C; Pan J; Kavanagh K; Ford I; McCowan C; Bennie M; Marwick C; Leanord A
    J Hosp Infect; 2020 Nov; 106(3):554-561. PubMed ID: 32717202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in U.S. Burden of
    Guh AY; Mu Y; Winston LG; Johnston H; Olson D; Farley MM; Wilson LE; Holzbauer SM; Phipps EC; Dumyati GK; Beldavs ZG; Kainer MA; Karlsson M; Gerding DN; McDonald LC;
    N Engl J Med; 2020 Apr; 382(14):1320-1330. PubMed ID: 32242357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual effect of community antimicrobial exposure on risk of hospital onset healthcare-associated Clostridioides difficile infection: a case-control study using national linked data.
    Pan J; Kavanagh K; Marwick C; Davey P; Wuiff C; Bryson S; Robertson C; Bennie M
    J Hosp Infect; 2019 Nov; 103(3):259-267. PubMed ID: 31173780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.
    Al-Tawfiq JA; Rabaan AA; Bazzi AM; Raza S; Noureen M
    Am J Infect Control; 2020 Oct; 48(10):1152-1157. PubMed ID: 32122671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
    Schechner V; Fallach N; Braun T; Temkin E; Carmeli Y
    J Antimicrob Chemother; 2021 Jul; 76(8):2182-2185. PubMed ID: 33969419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.
    Slimings C; Riley TV
    J Antimicrob Chemother; 2021 Jun; 76(7):1676-1688. PubMed ID: 33787887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excess burden associated with Clostridioides difficile infection in haematological patients occurring during hospitalization with induction chemotherapy in the USA.
    Duhalde L; Lurienne L; Wingen-Heimann SM; Guillou L; Buffet R; Bandinelli PA
    J Hosp Infect; 2020 Apr; 104(4):560-566. PubMed ID: 31870888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between statewide adoption of the CDC's Core Elements of Hospital Antimicrobial Stewardship Programs and rates of methicillin-resistant
    Garcia Reeves AB; Lewis JW; Trogdon JG; Stearns SC; Weber DJ; Weinberger M
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):430-437. PubMed ID: 31858919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network.
    Turner NA; Grambow SC; Woods CW; Fowler VG; Moehring RW; Anderson DJ; Lewis SS
    JAMA Netw Open; 2019 Oct; 2(10):e1914149. PubMed ID: 31664443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals.
    Tamma PD; Miller MA; Dullabh P; Ahn R; Speck K; Gao Y; Scherpf E; Cosgrove SE
    JAMA Netw Open; 2021 Feb; 4(2):e210235. PubMed ID: 33635327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial Differences in Clostridium difficile Infection Rates Are Attributable to Disparities in Health Care Access.
    Mao EJ; Kelly CR; Machan JT
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6283-7. PubMed ID: 26248363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case-control study of Clostridioides difficile in a rural health care area.
    Muñoz Cuevas C; Asencio Egea MÁ; Franco Huerta M; Huertas Vaquero M; Arias Arias Á; Carranza González R
    Gastroenterol Hepatol; 2023 Jan; 46(1):1-9. PubMed ID: 35104606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
    Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.